We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$11.9M – – –
IVM
2
InterWest Venture Management
California
$11M – – –
BB
3
BB Biotech
Switzerland
$10.8M +$1.66M +11,635 +21%
FM
4
Frazier Management
Washington
$10.6M – – –
AC
5
Aisling Capital
New York
$8.27M – – –
BC
6
Broadfin Capital
New York
$6.64M +$29.3K +206 +0.5%
Millennium Management
7
Millennium Management
New York
$4.9M +$109K +768 +3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$4.48M +$1.79M +12,612 +84%
OFM
9
Omega Fund Management
Massachusetts
$3.6M – – –
RSCM
10
Rock Springs Capital Management
Maryland
$2.43M – – –
TCM
11
Tekla Capital Management
Massachusetts
$2.32M – – –
EAM
12
Eventide Asset Management
Massachusetts
$2.14M – – –
DCM
13
DAFNA Capital Management
California
$1.69M – – –
Deutsche Bank
14
Deutsche Bank
Germany
$1.45M +$1.02M +7,148 +396%
Renaissance Technologies
15
Renaissance Technologies
New York
$1.15M +$46.9K +330 +5%
GC
16
Guggenheim Capital
Illinois
$982K -$148K -1,041 -15%
WFI
17
West Family Investments
California
$810K – – –
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$791K +$12.5K +88 +2%
BCM
19
Bridgeway Capital Management
Texas
$559K +$178K +1,250 +57%
BlackRock
20
BlackRock
New York
$541K +$137K +960 +40%
SM
21
Sabby Management
Florida
$521K -$432K -3,035 -49%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$405K -$100K -705 -22%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$388K – – –
JP Morgan Chase
24
JP Morgan Chase
New York
$328K +$128K +900 +77%
TMC
25
Trellus Management Company
Florida
$324K -$35.6K -250 -11%